Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on the Safety and Effects of ORG-129 in Patients with Fibrostenotic Crohn's Disease
AustriaStudy on the Effects of High-Flow Oxygen Therapy in Patients with Interstitial Lung Disease During Exercise
SpainStudy on Rituximab for Patients with Generalized Myasthenia Gravis
ItalyStudy on Baricitinib for New-Onset Polymyalgia Rheumatica Patients to Reduce Steroid Use
AustriaStudy of Dupilumab's Effect on Airway Mucus in Adults with Severe Asthma
AustriaStudy on Omalizumab and Mepolizumab for Patients with Severe Allergic and Eosinophilic Asthma
BelgiumStudy of Desmopressin for Prevention of Bleeding After Kidney Biopsy in Patients with Rare Glomerulonephritis
PolandStudy of rituximab and belimumab combination compared to rituximab alone in adults with persistent or chronic immune thrombocytopenia (ITP)
FranceStudy on Risankizumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy of Isatuximab for Patients with Type I Cryoglobulinemia
FranceStudy on the Safety and Effectiveness of AZD8630 for Adults with Uncontrolled Asthma at Risk of Exacerbations
BelgiumStudy to Compare Weekly Islatravir/Lenacapavir with Bictegravir/Emtricitabine/Tenofovir in People with HIV-1 Who Are Virologically Suppressed
FranceThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
